Funding for this research was provided by:
National Cancer Institute (R21CA197752)
National Center for Advancing Translational Sciences (UL1TR000135)
Received: 18 December 2017
Accepted: 27 April 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: This retrospective analysis was compliant with the US Health Insurance Portability and Accountability Act and approved by the Mayo Clinic Institutional Review Board, which issued a waiver of informed consent.
: CBH and MKO receive royalties for licensed technologies per agreement between Mayo Clinic and Gamma Medica, a manufacturer of molecular breast imaging systems. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.